Mantle Cell Lymphoma - Is There a Survival Advantage?

The second and the third line therapies are so much better now in mantle cell lymphoma versus if you had done it 10 to 15 years ago we didn't have btk inhibitors. To show an overall survival advantage in the current state is going to be incredibly hard, he says. The patients who got into a cr likely could defer auto transplant if you gave our maintenance um down the road why because  of course by the time you did it they would be outdated.